Seventh Annual Recent Advances and New Directions in Cancer Therapy Conference, in Partnership With the California Cancer Consortium

The Center for Biomedical Continuing Education
Last Modified: January 23, 2008

Share article


Conference Dates: March 28-30, 2008
Conference Location: San Francisco, CA

Sponsoring Group: The CBCE™ (The Center for Biomedical Continuing Education)

Conference Web Page URL: www.thecbce.com

Topics Covered: Please visit www.thecbce.com or e-mail info@thecbce.com for information regarding the topics covered.

Conference Objectives: Please visit www.thecbce.com for information regarding conference objectives

Who Should Attend: Medical Oncologists, Radiation Oncologists, Surgical Oncologists, Community Practitioners, Advances Practitioners, Nurse Practitioners, Physician Assistants, and other health care professionals interested in the care and treatment of patients with cancer

Conference Agenda: Please visit www.thecbce.com or e-mail info@thecbce.com for information regarding the topics covered.

Registration Information: Participants can register on-line at www.thecbce.com

Conference Fees: Please visit www.thecbce.com for information regarding conference fees

Continuing Education: Yes


News
TCR-based gene therapy directed against NY-ESO-1 induced response in metastatic melanoma, sarcoma

Feb 3, 2011 - A T-cell receptor-based gene therapy directed against NY-ESO-1 cancer/testis antigen may represent a new therapeutic approach for patients suffering from melanoma and synovial cell sarcoma, according to a study published online Jan. 31 in the Journal of Clinical Oncology.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More